FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

ADHD news from FiercePharma

News

SPOTLIGHT: Shire gets Vyvanse nod for adult use

Shire got its longed-for blessing from the FDA to sell Vyvanse, an ADHD treatment, for use in adults. Some one-third of Vyvanse scrips already go to grownups, off-label, but the FDA OK will let Read more...
Tags: ADHD   FDA  

AHA: Kids need EKG before ADHD meds

The American Heart Association isn't making any friends among ADHD drug makers today. The health charity is recommending that kids get an EKG before taking stimulant drugs like Ritalin for Read more...
Tags: Ritalin   ADHD   drug safety  

Pros use pills to boost brainpower

Fuzzy-headed today? Then pop a pill. Professionals of all kinds are doing it these days, according to a survey taken by Nature. Read more...
Tags: Ritalin   Provigil   Novartis   FDA   drug abuse   ADHD   Adderall  

What's Shire doing to support Vyvanse?

Are worries about Shire's Adderall successor justified? The Wall Street Journal Health Blog asked Read more...
Tags: Pfizer   ADHD   FDA  

New drug warnings poised for rollout

New warnings and warning recommendations are flying out of the FDA this week like geese flying south for the winter, partly because of an FDA advisory panel is meeting. Here's the latest:Committee Read more...

Shire casts off non-core drugs for $213M

UK-based Shire Pharmaceuticals is selling a block of medicines to Almirall of Read more...
Tags: FDA   ADHD   Shire   Almirall   Solaraze   Vaniqua  

Roche to Dr. Reddy's: Back off Boniva

Roche has no intention of letting Boniva go gently into that generic night. On the heels of a Read more...

Feds to study ADHD drugs for heart risks

Do they or don't they? The feds aim to find out whether drugs for attention deficit hyperactivity disorder actually increase the risk of heart problems. The FDA and the Agency for Healthcare Read more...

Press Releases

PRESS RELEASE: AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications

AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive Read more...

FDA STATEMENT: AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications

AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive Read more...

Get more ADHD coverage at: